Endotoxin and tryptophan-induced hypoglycaemia in rats |
| |
Authors: | Peter Lloyd Donald Stribling Christopher I. Pogson |
| |
Affiliation: | 1. Biological Laboratory, University of Kent, Canterbury CT2 7NJ, U.K.;2. Pharmaceuticals Division, Imperial Chemical Industries, Alderley Park, Macclesfield SK10 4TG, U.K. |
| |
Abstract: | ![]() Pretreatment of rats with increasing, but non-lethal, doses of endotoxin was associated with a parallel increase in sensitivity to induction of hypoglycaemia by tryptophan. Acutely streptozocin-diabetic animals became hypoglycaemic with endotoxin alone, and this was increased further by tryptophan. Variations in tryptophan sensitivity between rat populations cannot be explained by previous history of exposure to endotoxin. Endotoxin abolished the increase in tryptophan dioxygenase activity caused by triamcinolone, but not that caused by tryptophan. Triamcinolone was effective, however, when given together with tryptophan to endotoxin-treated rats. The activity of tryptophan dioxygenase in vivo and in liver cells in vitro is unchanged by exposure to endotoxin at 1 mg/kg body wt. Turnover studies indicated that hypoglycaemia resulted from inhibition of gluconeogenesis. There was no evidence to support a role for insulin in this process and results were consistent with an endotoxin-mediated hepatic insensitivity to glucagon. They also suggested that quinolinate, rather than 5-hydroxytruptamine, may be the intracellular agent responsible for inhibition of gluconeogenesis. |
| |
Keywords: | Present address: Nuffield Department of Clinical Biochemistry University of Oxford John Radcliffe Hospital Headington Oxford OX3 9DU U.K. (to whom correspondence should be addressed) |
本文献已被 ScienceDirect 等数据库收录! |
|